On April 11, 2025, a scientific and practical event titled “Atherosclerosis School” took place at the Diagnostic Center of the East Kazakhstan Regional Hospital in Ust-Kamenogorsk. The seminar brought together physicians from various specialties interested in modern approaches to the diagnosis and treatment of dyslipidemia and atherosclerosis.

The seminar featured a series of lectures covering key topics—from the mechanisms of atherosclerosis development and its complications to the role of lipid fractions, modern diagnostic methods, and targeted therapy. Special attention was given to hypolipidemic therapy, management strategies for patients at cardiovascular risk, and familial hypercholesterolemia.

Participants also reviewed clinical cases, including the management of dyslipoproteinemia and elevated Lp(a) levels. The program concluded with a focus on an often-overlooked topic—lipodystrophy as a differential diagnosis in cases of hypertriglyceridemia.

The event was held in a dynamic, practice-oriented format and generated significant interest among healthcare providers. Participants appreciated the relevance of the content and the opportunity to apply the knowledge directly in clinical practice.

The organizers express their gratitude to all attendees for their engagement and commitment to professional development. Events like this play a key role in sharing expertise and improving the quality of healthcare in the region.

#rarediseasecompanykazakhstan #businessdevelopmentinkazakhstan #PharmandAccess #CentralAsia #ChiesiGlobalRare #orphandiseasepatientsinKazakhstan #orphanpharmaceuticalcompanyinKazakhstan #rarediseasepatientsinCentralAsia #orphanpharmacompany